Comprehensive analysis of Nippon India Nifty Alpha Low Volatility 30 IF-Dir (G) (43035) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Nippon Life India Asset Management Ltd
The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Alpha Low Volatility 30 Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
Low Expense Ratio
Equity Focused
Established Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Market exposure level
Outperformance vs benchmark
Fund management costs
Historical performance consistency
Fund manager experience
Recent performance momentum
Assets under management
Risk-adjusted returns
This fund has underperformed its benchmark by 0.75% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| ICICI Bank Ltd | Banks | 4.62% |
| HDFC Bank Ltd | Banks | 4.48% |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.36% |
| ITC Ltd | Tobacco Products | 4.19% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 4.14% |
| HDFC Life Insurance Company Ltd | Insurance | 3.96% |
| Britannia Industries Ltd | FMCG | 3.87% |
| Bharti Airtel Ltd | Telecomm-Service | 3.87% |
| Divis Laboratories Ltd | Pharmaceuticals | 3.75% |
| Dr Reddys Laboratories Ltd | Pharmaceuticals | 3.71% |
Compare against Index Fund category average
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1230.12 | 4.26% | 8.39% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1230.12 | 4.26% | 8.39% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1225.70 | 4.18% | 8.23% | N/A |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1225.68 | 4.18% | 8.23% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1208.94 | 4.38% | 8.21% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1208.94 | 4.38% | 8.21% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1204.58 | 4.31% | 8.05% | N/A |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1204.56 | 4.31% | 8.05% | N/A |
| HDFC BSE Sensex Index Fund - Direct | ₹766.86 | 11.07% | -1.48% | 12.15% |
| HDFC BSE Sensex Index Fund - Regular | ₹748.57 | 10.99% | -1.63% | 11.97% |
A seasoned investment professional with over 3 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.